Therapeutic use of PACAP, Maxadilan, PACAP receptor agonist and/or ADCYAP1R1 in the treatment of CNS disorders

Details for Australian Patent Application No. 2003228050 (hide)

International Classifications

Event Publications

14 August 2003 Complete Application Filed

Priority application(s): 60/377,734 03.05.02 US; 60/393,264 02.07.02 US; 60/426,827 15.11.02 US

8 January 2004 Application Open to Public Inspection

Published as AU-A-2003228050

26 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.